DRIVE: a comprehensive resource deciphering drug-induced transcriptomic and splicing response in cancer cell
The DRIVE database was constructed as a comprehensive resource detailing drug-induced transcriptomic and splicing responses and identified Osimertinib as a potential immunomodulatory agent associated with transcriptional signatures of an activated tumor microenvironment, while KB-0742 emerged as an unappreciated candid...